Markets:

Overview

News

Currencies

International

Treasuries

Vericel Corporation - Common Stock (NQ:VCEL)

42.54 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Vericel Corporation - Common Stock

< Previous 1 2 3 4 Next >

Vericel Corp (NASDAQ:VCEL) Emerges as a Top Affordable Growth Candidate ↗

November 12, 2025

Vericel (VCEL) offers affordable growth in biotech with strong revenue & earnings, solid financials, and a reasonable valuation relative to peers.

Via Chartmill

Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings ↗

November 06, 2025

Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings

Via The Motley Fool

Topics Regulatory Compliance

Vericel (VCEL) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Vericel (VCEL) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Vericel Corporation (NASDAQ:VCEL) Surpasses Earnings Estimates with Strong Q3 2025 Results ↗

November 06, 2025

Vericel (VCEL) beats Q3 2025 earnings estimates with strong revenue growth and a swing to profitability, driven by its MACI and burn care products.

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Where Vericel Stands With Analysts ↗

February 28, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

What 7 Analyst Ratings Have To Say About Vericel ↗

February 03, 2025

Via Benzinga

Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup ↗

November 06, 2025

Vericel (VCEL) combines strong revenue & earnings growth with a bullish technical setup, making it a top biotech growth stock to watch.

Via Chartmill

This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

September 17, 2025

Via Benzinga

MediWound Revenue Jumps 43% in Q2 ↗

August 14, 2025

Via The Motley Fool

Vericel Corp (NASDAQ:VCEL): A High-Growth Stock with a Promising Technical Setup ↗

August 14, 2025

Vericel Corp (VCEL) is a high-growth biotech stock with strong fundamentals and a promising technical setup, making it a potential breakout candidate for investors.

Via Chartmill

Vericel Q2 Revenue Jumps 20% ↗

August 05, 2025

Via The Motley Fool

Topics Intellectual Property

Beyond The Numbers: 5 Analysts Discuss Vericel Stock ↗

January 15, 2025

Via Benzinga

Earnings Preview For Vericel ↗

November 06, 2024

Via Benzinga

The Analyst Verdict: Vericel In The Eyes Of 7 Experts ↗

August 27, 2024

Via Benzinga

Vericel Corp (NASDAQ: VCEL) Posts Mixed Q2 2025 Results with Revenue Miss and EPS Beat ↗

July 31, 2025

Vericel Corp (VCEL) posted mixed Q2 2025 results with revenue missing estimates but EPS beating expectations. Shares fell 6.5% pre-market despite strong MACI growth and margin expansion.

Via Chartmill

VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with Technical Breakout Potential ↗

July 02, 2025

VERICEL CORP (NASDAQ:VCEL) shows strong growth fundamentals and a technical breakout pattern, making it a stock to watch in the biotech sector.

Via Chartmill

VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with Technical Breakout Potential ↗

June 06, 2025

VERICEL CORP (NASDAQ:VCEL) shows strong revenue and earnings growth, backed by a solid balance sheet and a promising technical breakout pattern.

Via Chartmill

What Analysts Are Saying About Vericel Stock ↗

May 22, 2025

Via Benzinga

VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with a Technical Setup ↗

May 16, 2025

VERICEL CORP (NASDAQ:VCEL) shows strong growth potential with solid profitability and a promising technical setup, making it a stock worth watching.

Via Chartmill

Expert Ratings For Vericel ↗

August 09, 2024

Via Benzinga

The Latest Analyst Ratings For Vericel ↗

August 02, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Vericel Through 4 Analysts ↗

July 16, 2024

Via Benzinga

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

January 15, 2025

Via Benzinga

Vericel Stock Sees RS Rating Shoot Higher ↗

November 11, 2024

The Relative Strength (RS) Rating for Vericel stock entered a higher percentile Monday, as it got a lift from 69 to 79.

Via Investor's Business Daily

Smaller Cap Biotechs Are In Season: How Are We Doing? ↗

November 07, 2024

SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.

Via Talk Markets

Apple To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday ↗

August 02, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.